Sandhill Capital Partners’s Gain Therapeutics GANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$27.7K Hold
15,400
﹤0.01% 97
2025
Q1
$29.4K Hold
15,400
﹤0.01% 88
2024
Q4
$33.3K Hold
15,400
﹤0.01% 92
2024
Q3
$27.4K Buy
+15,400
New +$27.4K ﹤0.01% 90